Clinical Approach to Diagnosis and Management of Cancer of the Cervix and Vulva

Surgical Pathology Clinics

Volumn 4, Issue 1, 2011, Pages 1-16

  Long, Kara C ^a   Abu Rustum, Nadeem R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer staging; Cervix cancer; Gynecologic malignancies; Treatment gynecologic cancer; Vulva cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ALGORITHM; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MEDICAL DECISION MAKING; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; UTERINE CERVIX CANCER; VULVA CANCER; VULVA CARCINOMA;

EID: 79951777279     PISSN: 18759181     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.path.2010.12.005     Document Type: Review

References (56)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
2. Viscidi R.P., Schiffman M., Hildesheim A., et al. Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population based study in Costa Rica. Cancer Epidemiol Biomarkers Prev 2004, 13:324-327.
3. Jones W.B., Shingleton H.M., Russell A.H., et al. Patterns for invasive cervical cancer: results of a national survey of 1984 and 1990. Cancer 1995, 76:1934-1947.
4. FIGO Committee on Gynecologic Oncology Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009, 105:103-104.
5. Society of Gynecologic Oncology Clinical practice guidelines: cervical cancer. Oncology 1998, 12:134-138.
6. Morris M., Mitchell M.F., Silva E.G., et al. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993, 51:193-196.
7. Benedet J.L., Anderson G.H. Stage IA carcinoma of the cervix revisited. Obstet Gynecol 1996, 87:1052-1059.
8. Ostos A.G. Studies on 200 cases of early squamous cell carcinoma of the cervix. Int J Gynecol Pathol 1993, 12:193-207.
9. Wolf J.K., Levenback C., Malpica A., et al. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol 1996, 88:82-86.
10. Poynor E.A., Barakat R.R., Hoskins W.J. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995, 57:158-164.
11. Im D.D., Duska L.R., Rosenshein N.B. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995, 59:179-182.
12. Ostor A., Roma R., Quinn M. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol 1997, 89:88-93.
13. Spirtos N.M., Schlaerth J.B., Kimball R.E., et al. Laparoscopic radical hysterectomy (tyle III) with aortic and pelvic lymphadenectomy. Am J Obstet Gynecol 1996, 174:1763-1767. [discussion: 1767-8].
14. Renaud M.C., Plante M., Roy M. Combined laparoscopic and vaginal radical surgery in cervical cancer. Gynecol Oncol 2000, 79:59-63.
15. Roy M., Plante M., Renaud M.C., et al. Vaginal radical hysterectomy versus abdominal radical hysterectomy in the treatment of early stage cervical cancer. Gynecol Oncol 1996, 62:336-339.
16. Schneider A., Possover M., Kamprath S., et al. Laparoscopy-assisted radical vaginal hysterectomy modified according to Schauta-Stoeckel. Obstet Gynecol 1996, 88:1057-1060.
17. Querleu D. Laparoscopically assisted radical vaginal hysterectomy. Gynecol Oncol 1993, 51:248-254.
18. Dargent D., Martin X., Sacchetoni A., et al. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 2000, 88:1877-1882.
19. Morrow C.P., Curtin J.P. Surgery for cervical neoplasia. Mitchell J, Hardy J, Birch DJ, editors. Gynecol cancer surgery 1996, 451-568. Churchhill Livingstone Inc, New York.
20. DiSaia P.J. Surgical aspects of cervical carcinoma. Cancer 1981, 48:548-559.
21. Piver S.M., Rutledge F., Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974, 44:265-272.
22. Abu-Rustum N.R., Sonoda Y., Black D., et al. Fertility sparing radical trachelectomy for cervical carcinoma: technique and review of the literature. Gynecol Oncol 2006, 103:807-813.
23. Diaz J.P., Sonoda Y., Leitao M.M., et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol 2008, 111:255-260.
24. Peters W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant treatment after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000, 18:1606-1613.
25. Sedlis A., Bundy B.N., Rotman M.Z., et al. A randomized trial of pelvic radiation versus no further treatment in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol 1999, 73:177-183.
26. Sutton G.P., Bundy B.N., Delgado G., et al. Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1992, 166:50-53.
27. Hoskins W.J. Prognostic factors for risk of recurrence in stage IB and IIA cervical cancer. Baillieres Clin Obstet Gynaecol 1988, 2:817-828.
28. Dargent D., Frobert L., Beau G. V factor (tumor volume) and T factor (FIGO classification) is the assessment of cervix cancer prognosis: the risk of lymph node spread. Gynecol Oncol 1985, 22:15-22.
29. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340:1154-1161.
30. Stehman F.B., Perez C.A., Kurman R.J., Thigpen J.T. Uterine cervix. Principles and practice of gynecologic oncology 1997, 758-858. Lippincott-Raven, Philadelphia. 2nd edition. W.J. Hoskins, C.A. Perez, R.C. Young (Eds.).
31. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999, 340:1137-1143.
32. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144-1153.
33. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999, 17:1339-1348.
34. Barber H.R. Relative prognostic significance of preoperative and operative findings in pelvic exenteration. Surg Clin North Am 1969, 49:431-447.
35. Shingleton H.M., Soong S.J., Gelder M.S., et al. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989, 73:1027-1034.
36. Curtin J.P., Hoskins W.J. Pelvic exenteration for gynecologic cancers. Surg Oncol Clin N Am 1994, 3:267-276.
37. Beller U., Sideri M., Maisonneuve P., et al. Carcinoma of the vagina. J Epidemiol Biostat 2001, 6:153-174.
38. Kurman R.J., Trimble C.L., Shah K.V. Human papilloma virus and the pathogenesis of vulvar carcinoma. Curr Opin Obstet Gynecol 1992, 4:582-585.
39. Carli P., De Magnis A., Mannine F., et al. Vulvar carcinoma associated with lichen sclerosis: experience at the Florence, Italy vulvar clinic. J Reprod Med 2003, 48:313-318.
40. Hietanen S.H., Kurvinen K., Syrjanen K., et al. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 1995, 173:1477-1479.
41. Trimble C.L., Hildesheim A., Brinton L.A., et al. Heterogenous etiology of squamous carcinoma of the vulva. Obstet Gynecol 1996, 87:59-64.
42. Manual for staging of cancer 1992, 177-180. JB Lippincott, Philadelphia. 4th edition. O.H. Beahrs, D.E. Henson, R.V. Hutter (Eds.).
43. Parry-Jones E. Lymphatics of the vulva. J Obstet Gynaecol Br Emp 1963, 70:751-755.
44. Iverson T., Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983, 16:179-182.
45. Kelley J.L., Burke T.W., Tornos C., et al. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol 1991, 144:240-245.
46. Farias-Eisner R., Cirisano F.D., Grouse D., et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T12-2N0-1M0) disease. Gynecol Oncol 1994, 53:55.
47. Figge C.D., Gaudenz R. Invasive carcinoma of the vulva. Am J Obstet Gynecol 1974, 119:382-387.
48. Rutledge F., Smith J.P., Franklin E.W. Carcinoma of the vulva. Am J Obstet Gynecol 1970, 106:1117-1121.
49. DeHulla J.A., Hollema H., Lolkema S., et al. Vulvar carcinoma. The price of less radical surgery. Cancer 2002, 95:2331.
50. Stehman F.B., Bundy B.N., Dvoretsky P.M., et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992, 79:490-494.
51. Bosquet J.G., Magrina J.F., Magtibay P.M., et al. Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva. Gynecol Oncol 2007, 105:742-746.
52. Homesley H.D., Bundy B.N., Sedlis A., et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecology Oncology Group study). Gynecol Oncol 1993, 49:279.
53. Hampl M., Hantschmann P., Michels W., et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol 2008, 111:282-288.
54. Parthasarathy A., Cheung M.K., Osann K., et al. The benefit of adjuvant radiation therapy in single node positive squamous cell vulvar carcinoma. Gynecol Oncol 2006, 103:1095.
55. DeHulla J.A., van der Zee A.G. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006, 60:38.
56. Hopkins M.P., Reid G.C., Morley G.W. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 1990, 75:1001-1007.